Vedolizumab IV (Entyvio™) ( DrugBank: Vedolizumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	4

96. クローン病

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-003509-13-BE (EUCTR)	06/10/2015	10/07/2015	Effect of Vedolizumab IV in subjects with Crohn's Disease	An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Activ ...	Crohn's Disease MedDRA version: 18.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Vedolizumab IV (Entyvio™) Product Name: Vedolizumab IV Product Code: MLN0002 INN or Propose ...	Takeda Development Centre Europe Ltd	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 3	United States;Czech Republic;Hungary;Canada;Poland;Belgium
2	EUCTR2014-003509-13-PL (EUCTR)	18/08/2015	12/06/2015	Effect of Vedolizumab IV in subjects with Crohn's Disease	An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Activ ...	Crohn's Disease MedDRA version: 19.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Vedolizumab IV (Entyvio™) Product Name: Vedolizumab IV Product Code: MLN0002 Other descript ...	Takeda Development Centre Europe Ltd	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 3	United States;Czech Republic;Hungary;Canada;Belgium;Poland
3	EUCTR2014-003509-13-CZ (EUCTR)	25/06/2015	27/04/2015	Effect of Vedolizumab IV in subjects with Crohn's Disease	An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Activ ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Vedolizumab IV (Entyvio™) Product Name: Vedolizumab IV Product Code: MLN0002 INN or Propose ...	Takeda Development Centre Europe Ltd	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 3	United States;Hungary;Czech Republic;Canada;Belgium;Poland
4	EUCTR2014-003509-13-HU (EUCTR)	15/05/2015	13/04/2015	Vedolizumab IV in subjects with Crohn's Disease	An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Activ ...	Crohn's Disease;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Vedolizumab IV (Entyvio™) Product Name: Vedolizumab IV Product Code: MLN0002	Takeda Development Centre Europe Ltd	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 3	United States;Czech Republic;Hungary;Canada;Belgium;Poland

First Previous1Next Last